Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NADPH-dependent oxidation of benzidine by rat liver

V M Lakshmi1, N T Zenser, F F Hsu

  • 1VA Medical Center and Department of Biochemistry and Division of Geriatric Medicine, St Louis University School of Medicine, MO 63125, USA.

Carcinogenesis
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of coronary artery bypass grafting: a 3 year analysis using the Society of Thoracic Surgeons Database.

Heart, lung & circulation·2005
Same author

Clinical-pathologic conference in general thoracic surgery: Disseminated nocardiosis presenting as Pancoast syndrome.

The Journal of thoracic and cardiovascular surgery·2004
Same author

Autoimmune myasthenia gravis: place of thymectomy and preferred technique.

Internal medicine journal·2003
Same author

Studies of phospholipid metabolism, proliferation, and secretion of stably transfected insulinoma cells that overexpress group VIA phospholipase A2.

Lipids·2001
Same author

Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: identification of 2-chlorohexadecanal.

The Journal of biological chemistry·2001
Same author

A novel mouse model of lipotoxic cardiomyopathy.

The Journal of clinical investigation·2001

beta-Naphthoflavone treatment significantly increases benzidine metabolism in rats, primarily via cytochrome P450 1A1/1A2. The main metabolite identified was 3-hydroxybenzidine, with its stability enhanced by ascorbic acid.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Toxicology

Background:

  • Benzidine is a known carcinogen.
  • Understanding its metabolic pathways is crucial for risk assessment.
  • Cytochrome P450 enzymes play a significant role in xenobiotic metabolism.

Purpose of the Study:

  • To investigate the NADPH-dependent oxidation of benzidine in rat liver microsomes.
  • To identify the specific cytochrome P450 isoforms involved in benzidine metabolism.
  • To characterize the major metabolites of benzidine and factors affecting their stability.

Main Methods:

  • Utilized liver microsomes from control and beta-naphthoflavone-treated rats.
  • Quantified benzidine metabolism using High-Performance Liquid Chromatography (HPLC).

Related Experiment Videos

  • Assessed protein and DNA binding of benzidine metabolites.
  • Employed cytochrome P450 inhibitors and mass spectrometry for metabolite identification.

    • Main Results:

    • Beta-naphthoflavone treatment increased benzidine metabolism (HPLC, protein, DNA binding) by 1.8- to 14.2-fold.
    • The primary aqueous soluble metabolite was identified as 3-hydroxybenzidine.
    • Cytochrome P450 1A1/1A2 were identified as the key enzymes involved.
    • Metabolism was inhibited by glutathione, N-acetylmethionine, and ascorbic acid.

    Conclusions:

    • Cytochrome P450 1A1/1A2 are responsible for the NADPH-dependent metabolism of benzidine to 3-hydroxybenzidine.
    • Ascorbic acid stabilizes 3-hydroxybenzidine, preventing its lability at pH > 7.0.
    • These findings contribute to understanding benzidine's metabolic activation and detoxification.